Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2023
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeksClaire M Keene, Tali Cassidy, Ying Zhao, et al.
Infectious Diseases and Therapy|April 2, 2025
Clinical Pharmacokinetics and Safety of Orally Administered VH4011499, a New HIV-1 Capsid Inhibitor, in Adults Without HIVNilay Thakkar, Rulan Griesel, Amy Pierce, et al.
NPJ Digital Medicine|September 23, 2020
CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIVPranav Rajpurkar, Chloe O'Connell, Amit Schechter, et al.
AIDS (London, England)|May 11, 2021
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimenClaire M Keene, Rulan Griesel, Ying Zhao, et al.
The Journal of Infectious Diseases|September 2, 2025
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Anti-drug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study ResultsPeter Leone, Alejandro Ferro, Charlotte-Paige Rolle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2026
Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept TrialRulan Griesel, Sebastian A Nuñez, Ezequiel Cordova, et al.
The Lancet. Infectious Diseases|March 18, 2020
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient dataDavid A Barr, Joseph M Lewis, Nicholas Feasey, et al.
Pageof 3